“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”

BACKGROUND: Patient-derived organoids (PDOs) from advanced colorectal cancer (CRC) patients could be a key platform to predict drug response and discover new biomarkers. We aimed to integrate PDO drug response with multi-omics characterization beyond genomics. METHODS: We generated 29 PDO lines from...

Descripción completa

Detalles Bibliográficos
Autores principales: Papaccio, Federica, García-Mico, Blanca, Gimeno-Valiente, Francisco, Cabeza-Segura, Manuel, Gambardella, Valentina, Gutiérrez-Bravo, María Fernanda, Alfaro-Cervelló, Clara, Martinez-Ciarpaglini, Carolina, Rentero-Garrido, Pilar, Zúñiga-Trejos, Sheila, Carbonell-Asins, Juan Antonio, Fleitas, Tania, Roselló, Susana, Huerta, Marisol, Sánchez del Pino, Manuel M., Sabater, Luís, Roda, Desamparados, Tarazona, Noelia, Cervantes, Andrés, Castillo, Josefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817273/
https://www.ncbi.nlm.nih.gov/pubmed/36604765
http://dx.doi.org/10.1186/s13046-022-02591-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817273/
https://www.ncbi.nlm.nih.gov/pubmed/36604765
http://dx.doi.org/10.1186/s13046-022-02591-z

Ejemplares similares